Xue J, Zhang J, Zhu J
Discov Oncol. 2024; 15(1):743.
PMID: 39630160
PMC: 11618281.
DOI: 10.1007/s12672-024-01649-y.
Sikder S, Bhattacharya A, Agrawal A, Sethi G, Kundu T
Heliyon. 2024; 10(19):e38193.
PMID: 39386816
PMC: 11462366.
DOI: 10.1016/j.heliyon.2024.e38193.
Ye W, Zhang C, Fan Z
Mol Biol Rep. 2024; 51(1):632.
PMID: 38724827
DOI: 10.1007/s11033-024-09577-4.
Galal M, Al-Rimawi M, Hajeer A, Dahman H, Alouch S, Aljada A
Int J Mol Sci. 2024; 25(7).
PMID: 38612893
PMC: 11012626.
DOI: 10.3390/ijms25074083.
Xiong H, Chen G, Fang K, Gu W, Qiu F
Curr Cancer Drug Targets. 2024; 24(11):1128-1143.
PMID: 38299400
DOI: 10.2174/0115680096271746240103063325.
The Sensitization of Triple-Negative Breast Cancers to Poly ADP Ribose Polymerase Inhibition Independent of BRCA1/2 Mutation Status by Chemically Modified microRNA-489.
Soung Y, Ju J, Chung J
Cells. 2024; 13(1).
PMID: 38201253
PMC: 10778461.
DOI: 10.3390/cells13010049.
Understanding crosstalk of organ tropism, tumor microenvironment and noncoding RNAs in breast cancer metastasis.
Chakraborty S, Banerjee S
Mol Biol Rep. 2023; 50(11):9601-9623.
PMID: 37792172
DOI: 10.1007/s11033-023-08852-0.
Combating breast cancer progression through combination therapy with hypomethylating agent and glucocorticoid.
Chu Y, Huang Y, Chiu P, Kuo W, Pan Y, Kuo Y
iScience. 2023; 26(5):106597.
PMID: 37128608
PMC: 10148121.
DOI: 10.1016/j.isci.2023.106597.
A Comprehensive Review on Pharmacological Activities of Pachypodol: A Bioactive Compound of an Aromatic Medicinal Plant Pogostemon Cablin Benth.
Fatima S, Farzeen I, Ashraf A, Aslam B, Ijaz M, Hayat S
Molecules. 2023; 28(8).
PMID: 37110702
PMC: 10141922.
DOI: 10.3390/molecules28083469.
MicroRNA-708 emerges as a potential candidate to target undruggable NRAS.
Pang J, Chien P, Kao M, Chiu P, Chen P, Hsu Y
PLoS One. 2023; 18(4):e0284744.
PMID: 37083947
PMC: 10120925.
DOI: 10.1371/journal.pone.0284744.
Calcium signalling pathways in prostate cancer initiation and progression.
Silvestri R, Nicoli V, Gangadharannambiar P, Crea F, Bootman M
Nat Rev Urol. 2023; 20(9):524-543.
PMID: 36964408
DOI: 10.1038/s41585-023-00738-x.
Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancer.
Sreekumar A, Saini S
Front Cell Dev Biol. 2023; 11:1075707.
PMID: 36711033
PMC: 9879360.
DOI: 10.3389/fcell.2023.1075707.
The Double Face of miR-708: A Pan-Cancer Player with Dissociative Identity Disorder.
de Oliveira J, Mathias C, Oliveira V, Pezuk J, Brassesco M
Genes (Basel). 2022; 13(12).
PMID: 36553642
PMC: 9777992.
DOI: 10.3390/genes13122375.
Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets.
Cui C, Zhang Y, Liu G, Zhang S, Zhang J, Wang X
Explor Target Antitumor Ther. 2022; 2(3):266-291.
PMID: 36046433
PMC: 9400724.
DOI: 10.37349/etat.2021.00046.
ST08 Altered NF-κB Pathway in Breast Cancer Cells as Revealed by miRNA-mRNA Analysis and Enhanced the Effect of Cisplatin on Tumour Reduction in EAC Mouse Model.
Nirgude S, Desai S, Mahadeva R, Ravindran F, Choudhary B
Front Oncol. 2022; 12:835027.
PMID: 35615145
PMC: 9125255.
DOI: 10.3389/fonc.2022.835027.
Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy.
Peppino G, Riccardo F, Arigoni M, Bolli E, Barutello G, Cavallo F
Cells. 2022; 11(1).
PMID: 35011736
PMC: 8750459.
DOI: 10.3390/cells11010172.
Transcriptional Control of Metastasis by Integrated Stress Response Signaling.
Lu S, Yang L, Cao Z, Zhao J, You J, Feng Y
Front Oncol. 2021; 11:770843.
PMID: 34746012
PMC: 8570279.
DOI: 10.3389/fonc.2021.770843.
Human microRNA similarity in breast cancer.
Jing Y, Li D
Biosci Rep. 2021; 41(10).
PMID: 34612484
PMC: 8529337.
DOI: 10.1042/BSR20211123.
Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer.
Cheng W, Wang H
Tzu Chi Med J. 2021; 33(3):224-232.
PMID: 34386358
PMC: 8323647.
DOI: 10.4103/tcmj.tcmj_220_20.
Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.
Pajares M, Alemany-Cosme E, Goni S, Bandres E, Palanca-Ballester C, Sandoval J
Int J Mol Sci. 2021; 22(14).
PMID: 34298969
PMC: 8306710.
DOI: 10.3390/ijms22147350.